Having trouble viewing this email? View as Webpage
My Northwestern Medicine August 17, 2022

Inflammatory Signaling Linked to Leukemia Progression

Inflammatory Signaling Linked to Leukemia Progression

An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.

Read more »

Scientists Identify Key Mechanism Controlling Skin Regeneration

A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.

Read more »

Emerging Therapy for Relapsed Lymphoma

An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.

Read more »

Scientists Discover Novel Cellular Mechanisms Behind Transcription Elongation

Northwestern Medicine investigators have discovered novel mechanisms underlying transcription elongation, the process of synthesizing RNA from DNA.

Read more »

Northwestern Medicine Opens New Cancer Center in Orland Park

The center offers hematology and medical oncology care, laboratory services, nutritional counseling and social work. A full-service infusion suite and specialty pharmacy provide onsite chemotherapy, immunotherapy, targeted therapy and supportive care.

Read more »

Dulai to Lead Hyperbaric Oxygen Therapy Study for Ulcerative Colitis

The clinical trial led by Parambir Dulai, MD, will further study the use of hyperbaric oxygen therapy to treat patients with ulcerative colitis flares who are hospitalized at Northwestern Medicine Lake Forest Hospital.

Read more »

Investigating Therapies for Genetic Epilepsy with Alfred George, Jr., MD

Have an idea for the newsletter or a comment on this issue?

Contact Us »